SpringWorks Therapeutics Inc (SWTX)
37.14
+0.59
(+1.61%)
USD |
NASDAQ |
Nov 15, 12:31
SpringWorks Therapeutics Free Cash Flow: -248.01M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -248.01M |
| March 31, 2024 | -244.89M |
| December 31, 2023 | -230.18M |
| September 30, 2023 | -225.73M |
| June 30, 2023 | -194.78M |
| March 31, 2023 | -185.48M |
| December 31, 2022 | -171.76M |
| September 30, 2022 | -163.62M |
| June 30, 2022 | -167.76M |
| March 31, 2022 | -159.82M |
| Date | Value |
|---|---|
| December 31, 2021 | -129.89M |
| September 30, 2021 | -67.06M |
| June 30, 2021 | -54.66M |
| March 31, 2021 | -37.42M |
| December 31, 2020 | -32.83M |
| September 30, 2020 | -63.95M |
| June 30, 2020 | -60.28M |
| March 31, 2020 | -57.23M |
| December 31, 2019 | -48.11M |
Free Cash Flow Range, Past 5 Years
-248.01M
Minimum
Jun 2024
-32.83M
Maximum
Dec 2020
-133.87M
Average
-159.82M
Median
Mar 2022
Free Cash Flow Benchmarks
| Ocugen Inc | -54.47M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -31.50M |
| iBio Inc | -18.55M |
| Theriva Biologics Inc | -18.01M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -41.79M |
| Cash from Investing (Quarterly) | 0.289M |
| Cash from Financing (Quarterly) | 3.371M |
| Free Cash Flow Per Share (Quarterly) | -0.7287 |
| Free Cash Flow to Equity (Quarterly) | -54.02M |
| Free Cash Flow Yield | -9.69% |